CN Patent

CN114177157B — 含有药物的立即释放片剂和用于形成片剂的方法

Assigned to Genentech Inc · Expires 2024-08-02 · 2y expired

What this patent protects

本公开总体上涉及含有为丝裂原活化蛋白激酶抑制剂的药物、填充剂和崩解剂的快速释放药物剂量单位片剂，以及用于形成所述片剂的方法。更具体地，本公开涉及含有考比替尼、至少一种填充剂、至少一种润滑剂和至少一种崩解剂的药物剂量单位片剂，以及用于由干法制粒而形成的颗粒制备所述片剂的方法。

USPTO Abstract

本公开总体上涉及含有为丝裂原活化蛋白激酶抑制剂的药物、填充剂和崩解剂的快速释放药物剂量单位片剂，以及用于形成所述片剂的方法。更具体地，本公开涉及含有考比替尼、至少一种填充剂、至少一种润滑剂和至少一种崩解剂的药物剂量单位片剂，以及用于由干法制粒而形成的颗粒制备所述片剂的方法。

Drugs covered by this patent

cobimetinib-fumarate (COBIMETINIB FUMARATE)

Patent Metadata

Patent number: CN114177157B
Jurisdiction: CN
Classification: —
Expires: 2024-08-02
Drug substance claim: No
Drug product claim: No
Assignee: Genentech Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.